In one case of classical Hodgkin lymphoma (cHL), the t(4;9)(q21;p24) translocation was observed, which resulted in a new oncogenic and enzymatically activated SEC1A-JAK2 fusion protein. The gene discussed is JAK2; the disease is classic Hodgkin lymphoma.